By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AngioScore (Acquired by Spectranetics) 

5055 Brandin Court

Fremont  California  94538  U.S.A.
Phone: 510-933-7900 Fax: 510-933-7901


Medical Device

Company News
QT Vascular Announces Another Positive Outcome In Litigation With Spectranetics (SPNC)/AngioScore, Inc. 2/11/2016 6:45:08 AM
Jury In Federal Court In California Finds Against AngioScore, Inc.'s Patent Infringement Claims 9/30/2015 9:00:41 AM
Federal Court In California Awards AngioScore, Inc. $20 Million Plus Disgorgement In Breach Of Fiduciary Duty Case 7/2/2015 7:40:28 AM
AngioScore, Inc. Launches New 200 Mm Length Angiosculpt® Scoring Balloon Catheters 7/10/2014 6:16:33 AM
Spectranetics Corporation (SPNC) Completes Acquisition Of AngioScore, Inc. 7/1/2014 10:25:21 AM
Spectranetics Corporation (SPNC) Agrees To Buy AngioScore, Inc. For $230 Million 5/28/2014 8:56:39 AM
AngioScore, Inc. Announces Preliminary Clinical Trial Results For The World’s First Drug-Coated Scoring Balloon Catheter 11/12/2013 10:08:54 AM
AngioScore, Inc. to Present Preliminary Data From the First-In-Human Study of the Drug-Coated AngioSculpt® Scoring Balloon Catheter at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco 10/17/2013 6:55:18 AM
AngioScore, Inc. Announces Completion of Enrollment in Drug-Coated AngioSculpt® Scoring Balloon Catheter First-in-Human Study 6/19/2013 10:01:54 AM
AngioScore, Inc. Announces PMA Supplement Approval Allowing a Summary of the AGILITY Coronary Bifurcation Trial Results in the AngioSculpt® IFU 6/12/2013 10:55:48 AM